VHCP Co-Investment Holdings II, LLC

10% owner at Adverum Biotechnologies, Inc. · on record since Aug 7, 2014
10% owner at Oruka Therapeutics, Inc. · on record since Jun 17, 2015
10% owner at Bellerophon Therapeutics, Inc. · on record since Sep 17, 2018
10% owner at KalVista Pharmaceuticals, Inc. · on record since Sep 10, 2018
10% owner at MARIZYME, INC. · on record since Mar 13, 2019
10% owner at CONSTAR INTERNATIONAL INC · on record since Dec 16, 2019
10% owner at Synvista Therapeutics, Inc. · on record since May 28, 2020
10% owner at Cogent, Inc. · on record since Aug 18, 2020
10% owner at Tricida, Inc. · on record since Jun 30, 2022
10% owner at Vistagen Therapeutics, Inc. · on record since Jul 14, 2022

Insider trading activity of VHCP Co-Investment Holdings II, LLC

Transactions on record: 10; since Aug 7, 2014

Open-market buys: 8; $19.4M

Open-market sells: 0

Companies traded: 4; last filing Jul 25, 2022

Figures computed from official regulatory filings — .

Companies where VHCP Co-Investment Holdings II, LLC has traded

Tricida, Inc.3 tx · $687.2K · Jul 25, 2022
Synvista Therapeutics, Inc.1 tx · $11.3M · Jun 15, 2020
Bellerophon Therapeutics, Inc.3 tx · $558.3K · Sep 12, 2018
Adverum Biotechnologies, Inc.3 tx · $6.8M · Aug 7, 2014

Track record of VHCP Co-Investment Holdings II, LLC

Open-market buys: 8

Last buy: Jul 25, 2022

Enough buys on record, but none of them has a 63-day return yet — this happens when the shares stopped trading, or when the buys are too recent. Win rates will appear once returns mature.

Transaction history of VHCP Co-Investment Holdings II, LLC

Co-insiders of VHCP Co-Investment Holdings II, LLC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	30,000	9.59 USD	$287.7K	conv 37ClusterFirst in 12mo	SEC
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	29,199	8.95 USD	$261.3K	conv 25Cluster	SEC
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	15,000	9.21 USD	$138.2K	conv 24Cluster	SEC
Synvista Therapeutics, Inc.Listing unverified	Jun 15, 2020	Buy	1,500,000	7.54 USD	$11.3M	conv 70Unusual sizeFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.14 USD	$228K	conv 34Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.22 USD	$244K	conv 51ClusterFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	75,000	1.15 USD	$86.3K	conv 25Cluster	SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	Other	1,965,471	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	OtherD (derivative)	-1,965,471	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	Buy	400,000	17.00 USD	$6.8M	conv 50ClusterFirst in 12mo	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	30,000	9.59 USD	$287.7K	conv 37ClusterFirst in 12mo	SEC
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	29,199	8.95 USD	$261.3K	conv 25Cluster	SEC
Tricida, Inc.Listing unverified	Jul 25, 2022	Buy	15,000	9.21 USD	$138.2K	conv 24Cluster	SEC
Synvista Therapeutics, Inc.Listing unverified	Jun 15, 2020	Buy	1,500,000	7.54 USD	$11.3M	conv 70Unusual sizeFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.14 USD	$228K	conv 34Cluster	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	200,000	1.22 USD	$244K	conv 51ClusterFirst in 12mo	SEC
Bellerophon Therapeutics, Inc.Listing unverified	Sep 12, 2018	Buy	75,000	1.15 USD	$86.3K	conv 25Cluster	SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	Other	1,965,471	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	OtherD (derivative)	-1,965,471	—	n/a (No price was disclosed in the filing)		SEC
Adverum Biotechnologies, Inc.Listing unverified	Aug 7, 2014	Buy	400,000	17.00 USD	$6.8M	conv 50ClusterFirst in 12mo	SEC